VC

Vivek Chandel

Active Director Director DIN 07692212
DIN 07692212 First appointment Jan 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2017
Shareholding value •••• Premium profile

About Vivek Chandel

Data last updated:

Vivek Chandel is a Director at Atharvmeilleur Healthcare India Private Limited (since 2017). The company operates in Pharma. Atharvmeilleur Healthcare India Private Limited reported revenue of ₹48.8 Lakh (FY 2025).

DIN 07692212
Primary Designation Director
Industry Pharma
First Appointment 30 Jan 2017
Oldest Company Age 11 yrs
Largest company Atharvmeilleur Healthcare India Private Limited · ₹48.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Jan 20172015₹48.8 Lakh (FY 2025)Active

Board colleagues of Vivek Chandel

Directorship timeline

Open interactive timeline →
Atharvmeilleur Healthcare India Private Limited
Premium access

Shareholding and investment profile for Vivek Chandel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Chandel

Vivek Chandel currently holds 1 directorship: Atharvmeilleur Healthcare India Private Limited (Director, since 30 Jan 2017, revenue ₹48.8 Lakh (FY 2025)).

Vivek Chandel was first appointed on 30 Jan 2017 as Director at Atharvmeilleur Healthcare India Private Limited.

The current boards of Vivek Chandel's companies include Ashwini Chandel (Atharvmeilleur Healthcare India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available